Bridgewater Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Bridgewater Advisors's VRTX Position: Q2 2026 in Review
Bridgewater Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 0.54% in Q2 2026, selling an estimated $2.66K and leaving 1,103 shares worth $519K. The position accounts for 0.03% of the portfolio, ranked #269.
Bridgewater Advisors first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $561K in Q1 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Bridgewater Advisors held 1,103 shares of Vertex Pharmaceuticals worth $519K as of Q2 2026.
- Bridgewater Advisors sold 6 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
- Vertex Pharmaceuticals made up 0.03% of Bridgewater Advisors's portfolio in Q2 2026, its #269 holding.
- Bridgewater Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Bridgewater Advisors's Vertex Pharmaceuticals position peaked at $561K in Q1 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.